Director/PDMR Shareholding

RNS Number : 9658P
GlaxoSmithKline PLC
01 April 2009
 





Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.


On 31 March 2009, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £10.55 per Ordinary share and $30.21 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2009 to 31 March 2009:



Non Executive Director

Ordinary Shares

American Depository
 Shares (ADS
s)

Sir Christopher Gent

3,199.05


Prof. Sir Roy Anderson

799.76


Dr Stephanie Burns


618.11

Mr Lawrence Culp


1,236.22

Sir Crispin Davis

2,488.150


Sir Deryck Maughan


1,236.22

Dr Daniel Podolsky


865.36

Sir Ian Prosser

1,599.53


Dr Ronaldo Schmitz

995.26


Mr Tom de Swaan

799.76


Sir Robert Wilson

740.52



The Company and the Non-Executive Directors were informed of these allocations on 1 April 2009.


This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


S M Bicknell

Company Secretary
1 April 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQFLFBKZBLBBV

Companies

GSK (GSK)
UK 100